volume 26, issue 5, P242-251 2018
DOI: 10.1007/s12471-018-1104-6
View full text
|
Sign up to set email alerts
|
Share

Abstract: BackgroundDual antiplatelet therapy (DAPT) remains the cornerstone therapy in the prevention of ischaemic events following drug-eluting stent (DES) implantation. Mandatory duration of DAPT after DES however, is a matter of debate. We aimed to evaluate safety and efficacy of short-term (up to 6 months) versus long-term (12 months) DAPT after DES implantation.MethodsWe searched PubMed, EMBASE, Cochrane databases, and international meetings for randomised clinical trials (RCTs) comparing short with long DAPT. We …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

1
5
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals